Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 8;2(1):e000114.
doi: 10.1136/lupus-2015-000114. eCollection 2015.

Significantly reduced lymphadenopathy, salivary gland infiltrates and proteinuria in MRL-lpr/lpr mice treated with ultrasoluble curcumin/turmeric: increased survival with curcumin treatment

Affiliations

Significantly reduced lymphadenopathy, salivary gland infiltrates and proteinuria in MRL-lpr/lpr mice treated with ultrasoluble curcumin/turmeric: increased survival with curcumin treatment

Biji T Kurien et al. Lupus Sci Med. .

Abstract

Objectives: Commercial curcumin (CU), derived from food spice turmeric (TU), has been widely studied as a potential therapeutic for a variety of oncological and inflammatory conditions. Lack of solubility/bioavailability has hindered curcumin's therapeutic efficacy in human diseases. We have solubilised curcumin in water applying heat/pressure, obtaining up to 35-fold increase in solubility (ultrasoluble curcumin (UsC)). We hypothesised that UsC or ultrasoluble turmeric (UsT) will ameliorate systemic lupus erythematosus (SLE) and Sjögren's syndrome (SS)-like disease in MRL-lpr/lpr mice.

Methods: Eighteen female MRL-lpr/lpr (6 weeks old) and 18 female MRL-MpJ mice (6 weeks old) were used. Female MRL-lpr/lpr mice develop lupus-like disease at the 10th week and die at an average age of 17 weeks. MRL-MpJ mice develop lupus-like disease around 47 weeks and typically die at 73 weeks. Six mice of each strain received autoclaved water only (lpr-water or MpJ-water group), UsC (lpr-CU or MpJ-CU group) or UsT (lpr-TU or MpJ-TU group) in the water bottle.

Results: UsC or UsT ameliorates SLE in the MRL-lpr/lpr mice by significantly reducing lymphoproliferation, proteinuria, lesions (tail) and autoantibodies. lpr-CU group had a 20% survival advantage over lpr-water group. However, lpr-TU group lived an average of 16 days shorter than lpr-water group due to complications unrelated to lupus-like illness. CU/TU treatment inhibited lymphadenopathy significantly compared with lpr-water group (p=0.03 and p=0.02, respectively) by induction of apoptosis. Average lymph node weights were 2606±1147, 742±331 and 385±68 mg, respectively, for lpr-water, lpr-CU and lpr-TU mice. Transferase dUTP nick end labelling assay showed that lymphocytes in lymph nodes of lpr-CU and lpr-TU mice underwent apoptosis. Significantly reduced cellular infiltration of the salivary glands in the lpr-TU group compared with the lpr-water group, and a trend towards reduced kidney damage was observed in the lpr-CU and lpr-TU groups.

Conclusions: These studies show that UsC/UsT could prove useful as a therapeutic intervention in SLE/SS.

Keywords: Autoantibodies; Autoimmunity; Sjøgren's Syndrome; Systemic Lupus Erythematosus; Treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Lymphadenopathy (at week 14) in the lpr-water, lpr-CU and lpr-TU groups of mice and ultrasoluble curcumin (UsC) uptake by Epstein–Barr virus (EBV) transformed human PBMCs. (a, A–C) EBV-transformed human PBMCs incubated with UsC for 1 min; (a, D–F) EBV-transformed human PBMCs incubated with UsC for 2 min; (a, G–I) EBV-transformed human PBMCs incubated with UsC for 4 min; (A, D, G) fluorescence; (B, E, H) transmitted light overlay; (C, F, I) merged image (fluorescence+transmitted light overlay); (b) lymphadenopathy in the lpr-water group (A–D), lpr-CU group (E–H) and lpr-TU group (I–L). Arrows point to enlarged lymph nodes; (c) enlarged image of UsC uptake by EBV-transformed human PBMCs. (Left panel) fluorescence; (middle panel) transmitted light overlay; (right panel) merged image (fluorescence+transmitted light overlay). CU, curcumin; TU, turmeric.
Figure 2
Figure 2
Urinary cell casts, lymph node weights and proteinuria in the lpr-water, lpr-CU and lpr-TU groups of mice. (a) Urinary cell casts in the lpr-water group. (A–D) Red or white cell casts in four individual mice belonging to the lpr-water group at week 14. None of the mice in the lpr-CU or lpr-TU group had urinary cell casts at week 14; (bA) average lymph node weights in the lpr-water, lpr-CU and lpr-TU groups of mice. Average lymph node weights: lpr-water group= 2606 mg; lpr-CU= 743 mg; lpr-TU=385 mg. *p=0.03, lpr-water group versus lpr-CU group; **p=0.02, lpr-water group versus lpr-TU group (Mann–Whitney U test). Values are given as means±SE for each group. Statistical analyses were done by Mann–Whitney U test and the p-value was arrived at to assess the statistical significance of the changes observed. p<0.05 was considered to be significant; (bB) Weight of lymph nodes at death for the lpr-water, lpr-CU and lpr-TU groups of mice; (c) proteinuria in the MRL-lpr/lpr and MRL-MpJ mice provided with water, CU or TU analysed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE) (third urine collection; week 11). In total, 20 µL urine from each mouse was electrophoresed on 4–20% SDS-PAGE gels and stained with Coomassie brilliant blue. Lanes 1–6: MpJ-water group; lanes 7–12: MpJ-CU group; lanes 13–18: MpJ-TU group; lanes 19–24: lpr-water group; lanes 25–29: lpr-CU group; lanes 31–36: lpr-TU group. Increased protein excretion can be seen in the lpr-water group compared with the lpr-CU, lpr-TU and control MpJ mice. CU, curcumin; TU, turmeric.
Figure 3
Figure 3
Antinuclear antibody (ANA) patterns (using HEp-2 ANA assay kit) and anti-dsDNA (analysed by Crithidia luciliae assay) in sera of the lpr-water, lpr-CU and lpr-TU groups of mice. (a) ANA patterns observed in sera (third bleed) (1:80 dilution) of the lpr-water group (A–C), lpr-CU group (D–F) and lpr-TU group (G–I); (b) anti-dsDNA observed in sera (first bleed) (1:100 dilution) of the lpr-water group (A–C), lpr-CU group (D–F) and lpr-TU group (G–I). Only results obtained from three animals are shown for each experimental group. CU, curcumin; TU, turmeric.
Figure 4
Figure 4
Anti-RNP/anti-Sm antibodies in sera (bleeds 1–5) and H&E stained sections of kidney/salivary gland of the MRL-lpr/lpr and MRL-MpJ mice provided with water, CU or TU. (aA) Anti-RNP and anti-Sm in sera of the lpr-water, lpr-CU and lpr-TU groups of mice. (aB) Anti-RNP and anti-Sm in sera of the MpJ-water, MpJ-CU and MpJ-TU groups of mice. Values for each bleed were normalised to an anti-Sm or anti-RNP-positive control. Values are given as means±SD for each group. Statistical analyses were done by Student's t test and the p-value was arrived at to assess the statistical significance of the changes observed. p<0.05 or lower was considered to be significant; (b) kidney and salivary gland histopathology. (A) lpr-water, (B) lpr-CU (C) lpr-TU and (D) control MpJ mice. Protein casts in kidney and cellular infiltrates in salivary gland are indicated by arrows. CU, curcumin; RNP, ribonucleoprotein; TU, turmeric.
Figure 5
Figure 5
Lesions, survival and cell apoptosis in the lpr-water, lpr-CU and lpr-TU groups of mice. (a) Lesions in the lpr-water (A–C), lpr-CU (D and E) and lpr-TU (F) groups. Circumferential erythematous lesions, unrelated to tail vein bleeding, seen in the lpr-water group. Arrows point to cuts made for tail bleeding. (b) Survival curve for the lpr-water, lpr-CU and lpr-TU groups of mice. There was no difference in the survival between the MRL-MpJ mice (used as control mice for the MRL-lpr/lpr mice) fed with water, curcumin or turmeric. The control MpJ mice provided water (MpJ-water), curcumin (MpJ-CU) or turmeric (MpJ-TU) were sacrificed at 260 days. (c) Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) of axillary lymph node section of the lpr-TU group mouse. Apoptotic cells are indicated by dUTP incorporation, shown by FITC labelling. (cA) Overlay of 4′,6-diamidino-2-phenylindole (DAPI) and FITC staining in the absence of terminal deoxynucleotidyl transferase. (cB) Overlay of DAPI and FITC staining in the presence of the enzyme. CU, curcumin; TU, turmeric.

References

    1. Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526–33. doi:10.1056/NEJMoa021933 - DOI - PubMed
    1. Alarcon-Segovia D. The pathogenesis of immune dysregulation in systemic lupus erythematosus. A troika. J Rheumatol 1984;11:588–90. - PubMed
    1. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006;15:308–18. doi:10.1191/0961203306lu2305xx - DOI - PubMed
    1. Ainiala H, Dastidar P, Loukkola J et al. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study. Scand J Rheumatol 2005;34:376–82. doi:10.1080/03009740510026643 - DOI - PubMed
    1. Aisen AM, Gabrielsen TO, McCune WJ. MR imaging of systemic lupus erythematosus involving the brain. AJR Am J Roentgenol 1985;144:1027–31. doi:10.2214/ajr.144.5.1027 - DOI - PubMed

LinkOut - more resources